Benzinga··Vandana SinghNovo Nordisk Widens Obesity Drug Gap as Lilly's Pill Launch Stumbles
Eli Lilly's obesity pill logged 1,390 first-week prescriptions versus Novo Nordisk's 3,071 in four days, as $NVO maintains commanding 113,354 weekly Wegovy prescriptions.
LLYNVOmarket sharepharmaceutical competition